Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Appointment of Chief Financial Officer

8th Jun 2012 13:03

RNS Number : 0113F
HydroDec Group plc
08 June 2012
 



8 June 2012

 

 

Hydrodec Group plc

("Hydrodec" or "the Company") 

 

Appointment of Chief Financial Officer

 

 

The Board of Hydrodec Group plc, the cleantech industrial oil re-refining group (AIM:HYR), is pleased to announce that Chris Ellis has been appointed as Chief Financial Officer Designate and will join the Company and the Board on 7 July 2012. He will be based in London, UK.

Paul Manchester will step down from the Board but will remain with Hydrodec based in Sydney; the Board would like to acknowledge the contribution Paul has made to the continued progress of Hydrodec.

 

Mr Ellis is a qualified chartered accountant and has more than 20 years' board level finance and management experience of running a range of large, complex international businesses as well as small and medium sized ventures, including a significant period within GE Capital. Since 2009, he has served as Global Chief Financial Officer of PPC Worldwide, a global healthcare business within UnitedHealth Group Inc, a New York Stock Exchange listed company with a market capitalisation of approximately US$60 billion.

Neil Gaskell, Chairman of Hydrodec, said: "Chris joins Hydrodec at an exciting time and I am delighted to welcome him to the Company. His extensive board and international business experience means Hydrodec has now assembled a world-class leadership team, under Ian Smale, to drive the business forward globally."

 

For further information please contact:

Hydrodec Group plc

020 7907 9220

Neil Gaskell, Chairman

Ian Smale, CEO

Mike Preen, Head of Corporate and Legal Affairs

Numis Securities Limited (Nominated adviser/ joint broker)

020 7260 1000

Nominated Adviser: Hugh Jonathan

Corporate Broker: David Poutney, Alex Ham

Cenkos Securities plc (Joint broker)

Corporate Finance: Adrian Hargrave

Sales: Christian Hobart

020 7397 8900

Luther Pendragon (PR adviser to Hydrodec)

020 7618 9100

Neil Thapar, Alexis Gore

 

 

The following information on Christopher Ellis is provided pursuant to AIM Rule 17:

 

Full name and age: Christopher John Ellis (51)

 

Current directorships/partnerships:

 

None

 

Previous directorships/partnerships (past 5 years):

 

Phoenix Film Partners LLP (LLP member)

 

 

 

Notes to Editors:

 

 

Hydrodec's technology is a proven highly efficient oil re-refining and chemical process which was initially targeted at the multi-billion US$ market for transformer oil used by the world's electricity industry and now supplies oil to several other industries. The Group takes spent transformer oil, including polychlorinated biphenyl ("PCB") contaminated oil, as the primary feedstock, which is then processed at its two plants enabling 99 per cent or greater recovery of oil for reuse while also eliminating PCBs, a toxic additive banned under international regulations, without environmentally harmful emissions.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBBGDLIUGBGDI

Related Shares:

HYR.L
FTSE 100 Latest
Value8,809.74
Change53.53